The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Authors
Keywords
-
Journal
BLOOD
Volume 121, Issue 8, Pages 1446-1454
Publisher
American Society of Hematology
Online
2012-12-07
DOI
10.1182/blood-2012-06-434803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The interaction of IQGAPs with calmodulin-like proteins
- (2011) Sevvel Pathmanathan et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
- (2011) D. A. Hume et al. BLOOD
- TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway
- (2011) S. Kant et al. GENES & DEVELOPMENT
- A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A
- (2011) J. N. LOZIER et al. HAEMOPHILIA
- Downregulation of CD40 Signal and Induction of TGF-β by Phosphatidylinositol Mediates Reduction in Immunogenicity Against Recombinant Human Factor VIII
- (2011) Puneet Gaitonde et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Impact of polymorphisms in genes involved in autoimmune disease on inhibitor development in Chinese patients with haemophilia A
- (2011) Y. Lu et al. THROMBOSIS AND HAEMOSTASIS
- IQGAP1 and IQGAP2 are Reciprocally Altered in Hepatocellular Carcinoma
- (2010) Colin D White et al. BMC GASTROENTEROLOGY
- Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
- (2010) J. ASTERMARK et al. HAEMOPHILIA
- New B-cell CD molecules
- (2010) Jessica Matesanz-Isabel et al. IMMUNOLOGY LETTERS
- Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A
- (2010) D. Chaves et al. International Journal of Immunogenetics
- Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation
- (2010) Kazuhito Gotoh et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Factor XIII: novel structural and functional aspects
- (2010) I. KOMÁROMI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice
- (2010) Jung Min Han et al. PLoS One
- DOCK2 Is a Microglial Specific Regulator of Central Nervous System Innate Immunity Found in Normal and Alzheimer’s Disease Brain
- (2009) Patrick J. Cimino et al. AMERICAN JOURNAL OF PATHOLOGY
- New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development
- (2009) K. KURNIK et al. HAEMOPHILIA
- Postmarketing surveillance study of KOGENATE®Bayer with Bio-Set®in patients with haemophilia A: evaluation of patients’ satisfaction after switch to the new reconstitution system
- (2009) N. VIDOVIC et al. HAEMOPHILIA
- Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
- (2009) A. PAVLOVA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms
- (2008) Xiaoyi Gao et al. GENETIC EPIDEMIOLOGY
- Practical aspects of imputation-driven meta-analysis of genome-wide association studies
- (2008) P. I.W. de Bakker et al. HUMAN MOLECULAR GENETICS
- Conserved domains of the class A scavenger receptors: evolution and function
- (2008) Dawn M. E. Bowdish et al. IMMUNOLOGICAL REVIEWS
- What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases
- (2008) J EVANS et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started